Article 105: The Legal Gateway to Ministerial Instructions
Updated: 2026-11-11 · GRZAN Regulatory Team · Verification date 2026-10-20
1. Key takeaways
Article 105 of Public Health Law No. 89 of 1981 consists of a single sentence: regulations, instructions, and announcements may be issued to facilitate the implementation of the law. It is the legal source of authority for every ministerial document the Iraqi Ministry of Health issues. From this GRZAN draws a methodological conclusion: in Iraq the object of a company’s compliance management is not one law but a stream of instructions, control rules, and announcements; the law supplies authority, not rules. Anyone who works through the Public Health Law article by article as if it were a compliance checklist will miss the very documents that actually bind them, and will never be able to explain why the accepting window can always demand things the law does not mention.
- Article 105 is a one-sentence empowerment clause and the basis of all MOH ministerial documents.
- Substantive rules are generated, amended, and repealed in ministerial instructions and notices, not in statute.
- Documents carry a three-tier hierarchy: statutes, numbered instructions and rules, and unnumbered notices with short validity windows.
- Documents without a number and date cannot be cited as regulation.
2. Legal basis
The instruments examined in this article, with identifiers, dates, and provisions, are tabulated below.
| Instrument | Number | Publication date | Provisions |
| Public Health Law No. 89 of 1981, as amended | No. 89 (1981) | Published in the Official Gazette 1981-08-17 | Article 105 |
| Instructions on the Execution of Public (Government) Contracts | No. 1 (2025) | Published in the Iraqi Gazette issue 4849, 2025-11-17 | Article 37 sixth paragraph (Council of Ministers may grant exceptions); Article 41 (repeal and transition); Article 42 (entry into force 90 days after publication) |
| COSQC fee instructions | No. 4 (2016) | Signed 2016-06-05; Article 2 provides effect from the date of issue | Made under Article 25 of the Federal General Budget Law No. 1 (2016) |
| KIMADIA notice on the change of applicable basis for tenders (addressed to companies and scientific offices) | No independent number (website notice) | June 2026 (PDF path 2026/06) | States that it has switched to the Instructions No. 1 of 2025 |
Source grade. Article 105 and the Public Contracts Instructions No. 1 of 2025: primary, verified from the gazette facsimile, provisions read page by page from the layout, with Arabic quotations to be proofread against the original pages before formal publication. COSQC Instruction No. 4 of 2016: primary, verified at page level from the official PDF. The KIMADIA notice of June 2026: primary, verified from an official-domain PDF.
Excerpts:
- Article 105: regulations, instructions, and announcements may be issued to facilitate the implementation of this law.
- Article 37, sixth paragraph (Instructions): the Council of Ministers, on the recommendation of the economic ministerial council and in cases of extreme necessity, may grant exceptions for some government contracts. This is the legal channel through which Council of Ministers Decision No. 592 of 2026 could authorise the MOH and KIMADIA to accept awards below estimated cost by up to 20 percent.
- Article 41 (Instructions): the Instructions No. 2 of 2014 remain applicable to contracts concluded under them; repealed from the date this instrument takes effect.
3. Expert insights
Insight 1: this is legislation of the externally delegated type. The parent law writes only the authorisation; substantive rules are generated, amended, and repealed inside ministerial documents. In China, the medical device regulation distributes classification, registration, and production and distribution licensing across an administrative regulation and accompanying rules, in a clear hierarchy searchable in one official database. Iraq has no unified official regulatory library; ministerial documents sit scattered across the PDF directories of the MOH, the Ministry of Planning, KIMADIA, and COSQC sites, with some pages login-gated or dead. The compliance workload is therefore distributed entirely differently: in China the difficulty is reading, in Iraq the difficulty is collecting.
Insight 2: refutation of the claim that Iraq has no device regulation, so no compliance is needed. The inference runs backwards. Absence at the statutory level means responsibility falls one hundred percent on ministerial documents, and those are harder to exhaust than a statute: they can be issued at directorate level, without a number, and can be posted in a website PDF directory for as little as 21 days. The real risk is never whether a law exists; it is whether the instruction in your hands is the current version.
Insight 3: the three tiers of documents trade stability against effect in reverse. Tier one is statute (No. 89 of 1981, stable and searchable). Tier two is instructions and control rules (numbered by year and citable, but frequently updated). Tier three is announcements and notices (no independent number, strongly time-bound, often with specific start and end dates). The overwhelming majority of obligations demanded of companies in tendering or customs clearance sit in tier three. GRZAN archives by tier and sets high-frequency review only for tier three.
Insight 4: documents without a number and date cannot be cited as regulation. The typical example is the widely circulated English reprint of the Registration Department’s Drug Registration Regulations. It states clearly that the body responsible for registration is the Registration Department of the Technical Affairs Directorate of the MOH, but the document itself carries no number and no issue date, and is hosted on an overseas industry body’s site. Such a document can evidence the department’s own stated position; it cannot be tagged as article X of Iraqi regulation. The test is simple: a document is citable only if it yields the Arabic full title, number, year, and gazette issue or official URL.
4. Practical recommendations
- GRZAN maintains a ministerial documents ledger for every Iraqi client, with nine fixed fields: Arabic full title, translated title, number and year, issuing body, gazette issue or official URL, effective and expiry dates, addressees, our corresponding obligation, reviewer, and next review date.
- The ledger is tiered; tier three (announcements and notices) is reviewed monthly, tier two (instructions and control rules) quarterly, tier one (statutes) annually. Practical estimate: this review cadence is an internal management arrangement (no official provision found).
- Whenever a new requirement is raised at customs, in tendering, or in a document supplement, obtain on the spot the Arabic title and number of the underlying document and enter it in the ledger the same day; where no number is obtainable, record it in the ledger as administrative practice, no document number.
- Wherever internal client reporting contains the phrase Iraqi regulation provides, check it against the ledger; entries without a matching record are rewritten as according to current Ministry of Health practice.
- Do not delete superseded documents; mark the repeal date and the number of the replacing document and archive them. Historical versions are the only basis for explaining questions such as why a 2014 contract still follows the old instructions (the dual-track transition in Article 41 is the classic case).
5. Verification checklist
- □ In the FAOLEX full text locate Article 105 and verify the Arabic wording and the part of the law in which it sits.
- □ Download the gazette original of the Public Contracts Instructions No. 1 of 2025 from the Ministry of Planning website and confirm the Article 37 sixth paragraph exception channel and the Article 41 transition arrangement.
- □ On the Ministry of Planning government contracts page confirm the Instructions No. 1 (2025) remain current and that the No. 2 (2014) instructions are repealed but continue to apply to contracts concluded under them.
- □ On cosqc.gov.iq/laws/instructions check the current instruction list and whether Instruction No. 4 (2016) has been replaced.
- □ Search the kimadia.gov.iq notices section (including the tenders forms page) month by month for new notices and update the ledger.
- □ Request from the Technical Affairs Directorate a list of instructions currently in force (the directorate site tec-moh.com returned HTTP 500 during this verification; retry needed).
- □ Recheck whether the official documents cited here have been superseded by later instructions or decisions (verification date for this article: 29 October 2026).
Regulatory information verified as of 29 October 2026.
How GRZAN can help. GRZAN provides medical device and IVD registration, quality system, authorised representative and local testing support for the Iraqi market. Our team manages KMOC (Kurdistan) and federal MOH registration procedures, and supports post-market vigilance obligations. Business enquiries: info@grzanglobal.com
Disclaimer
Prepared by GRZAN from publicly available regulation. It is provided for general information only and does not constitute legal advice. Legislation and official fees are subject to change by the competent authority.
About GRZAN
GRZAN (Global Regulatory Zone Access Navigator) — the global market-access navigator for medical devices and IVDs.
GRZAN is a specialist consultancy for medical device and IVD market access, providing end-to-end regulatory solutions across the product lifecycle and making international market entry simpler and faster.
Key figures. More than 25 wholly owned subsidiaries worldwide covering 50+ countries and regions; chosen by 100+ listed and leading Chinese device manufacturers, with 4,000+ successful cases; 12+ years in the sector and 200+ regulatory training sessions and seminars delivered.
What we do. Global market access: multi-country registration programmes, technical documentation, regulatory advice. Clinical evidence: clinical evaluation reports (CER), usability studies, overseas clinical investigations. Quality systems: ISO 13485, MDSAP, FDA QMSR and BGMP implementation and audit readiness. Authorised representative and licence-holder services across Southeast Asia, Latin America, the Middle East, Africa, Europe and North America.
Why GRZAN. A real operating entity, with the certificate held by the manufacturer: our direct overseas subsidiaries act as the compliant local holder, so the regulatory relationship stays clear and you keep control rather than being tied to a distributor. Direct access to the team: no time-zone gap, no language barrier, no cultural gap. Review points anticipated: we know what FDA 510(k), EU MDR, Southeast Asian, Latin American and Middle Eastern reviewers look for, which shortens timelines and reduces deficiency letters. Pathway planning: pre-decision analysis and risk assessment before you commit.
Every engagement rests on three commitments: efficiency through pre-submission review, certainty through a clear pathway, and stability through a licence-holder that stays in place.
Take your devices global with GRZAN
We work with manufacturers worldwide to open new markets with a clear regulatory pathway.
Contact us